715 related articles for article (PubMed ID: 26273671)
1. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.
Adela R; Banerjee SK
J Diabetes Res; 2015; 2015():490842. PubMed ID: 26273671
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15.
Berezin AE
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S154-7. PubMed ID: 26482961
[TBL] [Abstract][Full Text] [Related]
3. Growth-differentiation factor-15 in heart failure.
Kempf T; Wollert KC
Heart Fail Clin; 2009 Oct; 5(4):537-47. PubMed ID: 19631178
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor 15 in heart failure: an update.
Wollert KC; Kempf T
Curr Heart Fail Rep; 2012 Dec; 9(4):337-45. PubMed ID: 22961192
[TBL] [Abstract][Full Text] [Related]
5. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study.
Natali A; Nesti L; Venturi E; Shore AC; Khan F; Gooding K; Gates PE; Looker HC; Dove F; Goncalves I; Persson M; Nilsson J;
Diabetes Obes Metab; 2019 Feb; 21(2):412-416. PubMed ID: 30178545
[TBL] [Abstract][Full Text] [Related]
6. Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.
Wollert KC; Kempf T; Wallentin L
Clin Chem; 2017 Jan; 63(1):140-151. PubMed ID: 28062617
[TBL] [Abstract][Full Text] [Related]
7. The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update.
Arkoumani M; Papadopoulou-Marketou N; Nicolaides NC; Kanaka-Gantenbein C; Tentolouris N; Papassotiriou I
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):114-125. PubMed ID: 31663791
[TBL] [Abstract][Full Text] [Related]
8. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
[TBL] [Abstract][Full Text] [Related]
9. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.
Vila G; Riedl M; Anderwald C; Resl M; Handisurya A; Clodi M; Prager G; Ludvik B; Krebs M; Luger A
Clin Chem; 2011 Feb; 57(2):309-16. PubMed ID: 21164037
[TBL] [Abstract][Full Text] [Related]
10. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
11. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
Martinez CH; Freeman CM; Nelson JD; Murray S; Wang X; Budoff MJ; Dransfield MT; Hokanson JE; Kazerooni EA; Kinney GL; Regan EA; Wells JM; Martinez FJ; Han MK; Curtis JL;
Respir Res; 2017 Feb; 18(1):42. PubMed ID: 28245821
[TBL] [Abstract][Full Text] [Related]
12. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
13. Circulating GDF-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis.
Gohar A; Gonçalves I; Vrijenhoek J; Haitjema S; van Koeverden I; Nilsson J; de Borst GJ; de Vries JP; Pasterkamp G; den Ruijter HM; Björkbacka H; de Jager SCA
Int J Cardiol; 2017 Aug; 241():430-436. PubMed ID: 28389123
[TBL] [Abstract][Full Text] [Related]
14. Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study.
Wada H; Suzuki M; Matsuda M; Ajiro Y; Shinozaki T; Sakagami S; Yonezawa K; Shimizu M; Funada J; Takenaka T; Morita Y; Nakamura T; Fujimoto K; Matsubara H; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Masunaga N; Ishii M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
J Am Heart Assoc; 2020 Nov; 9(22):e018217. PubMed ID: 33170061
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor-15: a new biomarker in cardiovascular disease.
Kempf T; Wollert KC
Herz; 2009 Dec; 34(8):594-9. PubMed ID: 20024638
[TBL] [Abstract][Full Text] [Related]
16. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15 and its role in diabetes and cardiovascular disease.
Eddy AC; Trask AJ
Cytokine Growth Factor Rev; 2021 Feb; 57():11-18. PubMed ID: 33317942
[TBL] [Abstract][Full Text] [Related]
18. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiating factor-15 and its association with traditional cardiovascular risk factors: The African-PREDICT study.
Vermeulen B; Schutte AE; Gafane-Matemane LF; Kruger R
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):925-931. PubMed ID: 32278609
[TBL] [Abstract][Full Text] [Related]
20. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
